|
Online
registration currently open
Dubai-United Arab Emirates -
Wednesday, November 14th 2012 [ME NewsWire]
Elsevier
– the world-leading provider of scientific, technical and medical information
products and services – announced the scientific program of its highly anticipated 2nd Middle East Vaccine Congress, which will
be held from 14th-15th December, 2012, at the Rotana Beach Hotel & Resort
in Abu Dhabi, UAE. Organized in partnership with global communications and
event management company MCI, the two-day event is expected to secure
wide-spread regional participation, bringing together vaccine experts from the
healthcare industry, academia and government.
Set to tackle key issues related to
vaccine research, manufacturing, policy, safety and regulation, the 2nd
Middle East Vaccine Congress’s plenary sessions will delve into topics that
encompass vaccine safety, breakthroughs as well as future challenges. Speakers will include senior vaccine
professionals, researchers and policy-makers from Germany, Italy, the UK, the
UAE, KSA, Kuwait, Oman, Lebanon, Jordan and Egypt.
Amongst the event’s featured
keynotes are: Ms. Houda Langar,Regional Adviser of the Essential
Vaccines and Biologicals Policy (VAC Unit) at the World Health Organization -
Egypt; Ms. Farida Al Hosani, Manager of the Communicable Diseases
Department at the Health Authority Abu Dhabi (HAAD); Mr. Ziad Memish,Deputy
Minister for Public Health and a Professor at the College of Medicine at KSA’s
Alfaisal University; Mr. Fred Zepp,Medical Director & Chairman of
the Department of Pediatrics at Germany’s Johannes Gutenberg University; Mr. Muhieddine
Seoud, Vice Chairman ofand a Professor atthe Department of
Obstetrics and Gynecology at the American University of Beirut (AUB); and Mr. Ray
Spier, Emeritus Professor of Science and Engineering Ethics atthe UK’s
University of Surrey, among others.
"We’re very excited about this
year’s lineup of keynotes and panelists, all of who come from rich medical and
academic backgrounds and will offer invaluable insights into the latest issues,
developments and challenges facing the regional vaccine industry today,” said
Haifa Al Mughrabi, Regional Director of Elsevier ME. "As professional
congress organizers, we at Elsevier aim to create enabling platforms
that allow for constructive dialogue and industry progress in order to enhance
the quality and effectiveness of healthcare in the MENA. We are confident that
the 2nd Middle East Vaccine Congress will serve as such a platform, and
we encourage relevant professionals in the region to register while the
opportunity is still available.”
In addition to learning from
experts, opinion leaders and exhibiting organizations, Congress attendees will
have access to unique, high-quality content and industry updates; meet with a
range of exhibitors presenting cutting-edge products and services; and learn
about the development of vaccines for infectious diseases.
Online
registration will remain open until 6th December, with onsite
registration available on the first day of the Congress. To register online,
please visit www.vaccinecongress.ae.
-End-
About Elsevier
Elsevier is a world-leading provider
of scientific, technical and medical information products and services. The
Company works in partnership with global science and health communities to
publish more than 2,000 journals, including The Lancet and Cell, and close
to 20,000 book titles, including major reference works from Mosby and Saunders.
Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s
Nursing Suite, which enhance the productivity of science and health
professionals, and the SciVal suite and MEDai’s Pinpoint Review,
which help research and health care institutions deliver better outcomes more
cost-effectively. A global business headquartered in Amsterdam, Elsevier employs
7,000 people worldwide. The Company is part of Reed Elsevier
Group PLC, a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New
York Stock Exchange).
www.elsevier.com
About MCI
MCI is a globally integrated
Association, Communication and Event Management Company. Since 1987, MCI has
created corporate events, meetings and incentives; association and governmental
conventions, congresses, exhibitions; and managed and provided consulting to
associations. MCI’s mission is to help companies, governments and associations
bring people together to create meaningful connections and win.
MCI provides many stand-alone
solutions designed for those who only need a specific service to complete their
projects such as Destination Management, Sustainability Services, Technical and
Creative Production, Event Hospitality, Event Furniture and Decoration and
Registration Technology.
Visit the MCI website www.mci-group.com
for more information.
Contacts
Kavitha Prabhu
Manager – External Communications
MCI Middle East & India
www.mci-group.com/uae
Tel: +971 (4) 311 6300
|
